Bioceres Crop Solutions (US:BIOX)2025-09-09 12:30Financial Performance - FY25 revenue decreased by 28% to $335 million, compared to $465 million in FY24[12] - Crop Nutrition revenue decreased by 34% from $96.4 million in FY24 to $63.9 million in FY25[17] - Crop Protection revenue decreased by 20% from $227.2 million in FY24 to $181.9 million in FY25[17] - Seed & Integrated Products revenue decreased by 37% from $89.5 million in FY24 to $53.2 million in FY25[17] - Gross profit decreased by 29% year-over-year, from $186.6 million in FY24 to $131.7 million in FY25[22] - Adjusted EBITDA decreased from $81.4 million in FY24 to $28.3 million in FY25[29] Cash Flow - Net cash flows generated by operating activities increased by 27% from $41.7 million in FY24 to $53.0 million in FY25[31] - Net cash flows used in financing activities increased by 390% from $(10.1) million in FY24 to $(49.3) million in FY25[31] Strategic Initiatives - The company is pivoting its seed business to focus on trait development and partnerships for market access[41] - The company is refocusing its biological portfolio to prioritize profitability over topline growth[42] - The company expects $10-12 million in cost savings from restructuring efforts to streamline SG&A expenses[43]